Lensar (LNSR) Income towards Parent Company (2019 - 2026)
Lensar's (LNSR) quarterly Income towards Parent Company came in at $2.1 million in Q2 2026, up 133.9% year-over-year from $912356.0 in Q2 2025, and down 4.52% quarter-over-quarter from $2.2 million in Q1 2026.
Analysis
Lensar (LNSR) Income towards Parent Company (2019 - 2026) Analysis & Trends
Lensar (LNSR) has reported Income towards Parent Company for 8 consecutive years, with $2.1 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Income towards Parent Company rose 133.9% year-over-year to $2.1 million in Q2 2026; TTM through Jun 2026 was -$8.1 million, a 44.4% increase from a year earlier, with the FY2025 full-year figure at -$24.6 million, down 130.52% from the prior year.
- Income towards Parent Company was $2.1 million for Q2 2026 at Lensar, down from $2.2 million in the prior quarter.
- Over five years, Income towards Parent Company peaked at $2.2 million in Q1 2026 and troughed at -$7.6 million in Q3 2025.
- A 5-year average of -$3.5 million and a median of -$3.5 million in 2022 frame the typical range for Income towards Parent Company.
- Across the five-year window, Income towards Parent Company plunged 518.63% in 2025 and soared 138.58% in 2026, its largest moves.
- Over 5 years, Income towards Parent Company stood at -$2.6 million in 2022, then fell by 13.32% to -$3.0 million in 2023, then jumped by 56.13% to -$1.3 million in 2024, then slumped by 278.75% to -$4.9 million in 2025, then jumped by 143.37% to $2.1 million in 2026.
- The last three Income towards Parent Company figures came in at $2.1 million (Q2 2026), $2.2 million (Q1 2026), and -$4.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.42 Bn | 178.82 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.16 Bn | 118.94 Bn | 1.96 Bn |
| 3 | Medtronic | 118.41 Bn | 109.59 Bn | 6.34 Bn |
| 4 | Stryker | 104.45 Bn | 100.98 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.47 Bn | 65.93 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.46 Bn | 1.35 Bn |
| 7 | Alcon | 33.95 Bn | 32.50 Bn | 1.68 Bn |
| 8 | Dexcom | 32.24 Bn | 30.29 Bn | 830.00 Mn |
| 9 | Steris | 21.17 Bn | 20.68 Bn | 684.20 Mn |
| 10 | Lensar | 103.29 Mn | 89.73 Mn | 9.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.13 Mn |
| Mar 31, 2026 | 2.24 Mn |
| Dec 31, 2025 | -4.92 Mn |
| Sep 30, 2025 | -7.57 Mn |
| Jun 30, 2025 | -6.30 Mn |
| Mar 31, 2025 | -5.79 Mn |
| Dec 31, 2024 | -1.30 Mn |
| Sep 30, 2024 | -1.22 Mn |
| Jun 30, 2024 | -5.29 Mn |
| Mar 31, 2024 | -2.86 Mn |
| Dec 31, 2023 | -2.96 Mn |
| Sep 30, 2023 | -2.04 Mn |
| Jun 30, 2023 | -2.87 Mn |
| Mar 31, 2023 | -4.36 Mn |
| Dec 31, 2022 | -2.61 Mn |
| Sep 30, 2022 | -4.08 Mn |
| Jun 30, 2022 | -6.80 Mn |
| Mar 31, 2022 | -6.68 Mn |
| Dec 31, 2021 | -3.91 Mn |
| Sep 30, 2021 | -6.17 Mn |